One of the main concepts in toxicology and risk assessment is the identi cation of compound s with the least toxicity, gaining increased understanding of the underlying mechanisms of ef cacy and toxicity so as to accelerate the early selection of compound s for development . For this purpose, "cuttingedge" technologies , such as ow cytometry (FC), laser scanning cytometry (LSC) and confocal laser scanning microscopy (CLSM), have proved to be valuable tools. FC, LSC and CLSM have been successfully applied in a wide range of areas within toxicology and research including genetics, reproduction, dermatology, pathology and target organ toxicity. The scope of this paper is to give a short overview of the usefulness of the different laser applications. Speci c examples of the impact of these technologies will be presented or can be found in the references. Flow cytometry methods have been successfully applied in immunophenotyping , micronuclei scoring, polyploidy determination, apoptosis and cell cycle evaluation, cell proliferation and quanti cation. A three-parameter FC method for the analysis of testicular toxicity has also been established as an alternative to traditional histopathologica l methods. This method allows a large number of cells to be analysed in a short time and provides quantitative values to evaluate testicular damage in the rat. Laser scanning cytometry has been used in our unit for rat blood cell immunophenotyping , tumor proliferation, apoptosis and cell cycle analysis on minipig and rat skin and cardiac cells identi cation. The wide range of applications that can be applied with the LSC shows the enormous potential of this technology in research and development . Confocal laser scanning microscope was used in our laboratory, in collaboration with the research department, to investigate the mechanisms underlying hepatic lesions found in dogs, to detect brinogen in ux into rat lung, to explore the mechanism of eye toxicity and to quantify dopaminergi c bers in brain sections. Integrating these technologies within discovery pathology allowed us to understand disease processes with respect to their developmen t and subsequen t consequences . It contributes to descriptive pathologic diagnostic and allows a productive interaction with research and development . These technologies offer a range of novel applications and have been shown to be useful tools in terms of speci city, sensitivity, reliability, rapidity and quanti cation. Expertise in cutting-edge technologies , pathology and cell and molecular biology is essential to a successful and exible interaction across all therapeutic areas in drug discovery.
INTRODUCTION
One of the main concepts in toxicology and risk assessment is the identi cation of compounds with the least toxicity, gaining increased understanding of the underlying mechanisms of ef cacy and toxicity so as to accelerate the early selection of compounds for development. For this purpose, "cutting-edge" technologies, such as ow cytometry (FC), laser scanning cytometry (LSC) and confocal laser scanning microscopy (CLSM), have proved to be valuable tools. In the Preclinical Safety department at Novartis, FC, LSC and CLSM have been successfully applied in a wide range of areas within toxicology and research including genetics, reproduction, dermatology, pathology and target organ toxicity. The scope of this paper is to give a short overview of the usefulness of the different laser applications. Speci c examples of the impact of these technologies will be discussed and can be found in the references.
FLOW CYTOMETRY
Flow cytometry is the quantitative multiparameter measurement of physical characteristics of a cell. These include size, shape and internal complexity. Flow cytometry uses uorescent markers to determine cell component or function. The applications of ow cytometry are numerous, and have led to the widespread use of this instrument in both the biological and medical elds (17) . In addition, many ow cytome-ters have the ability to sort, or physically separate, particles of interest from a sample.
Flow cytometry methods have been successfully applied in immunophenotyping , micronuclei scoring (14) , polyploidy determination, apoptosis and cell cycle evaluation, cell proliferation and quanti cation (10, 13) . A three-parameter FC method for the analysis of testicular toxicity has also been established as an alternative to traditional histopathologica l methods (18) . This method allows a large number of cells to be analysed in a short time and provides quantitative values to evaluate testicular damage in the rat (19, 20) .
LASER SCANNING CYTOMETRY (LSC)
Laser scanning cytometry is a recently established laboratory technology, similar to ow cytometry, but with different capabilities and signi cant advantages compared to ow cytometry (7, 8) . Unlike ow cytometry, the LSC measures multicolor uorescence and light scatter of cells on slides: cross sections or cytologic preparations. In common with a ow cytometer, the LSC measures multicolor uorescence (up to four uorochromes are currently possible) and light scatter on a single cell basis. The LSC technology records the position and time measurement of each cell, allowing the correlation of biochemical and morphometric measurements. Cells of interest can be relocated, visually con rmed, restained, remeasured and photographed. The speed of analysis is signi cantly slower than ow cytometry-the former measuring thousands of cells per minute or several minutes with the latter measuring the same number in seconds-but in certain situations the ability to visualize cells can be a 11 0192-6233/02$3.00 $0.00 distinct advantage. An additional advantage of LSC is that the data obtained are more complex than a standard ow cytometer. Certain features such as area, perimeter, maximum pixel value and texture can give additional information useful in characterizing differences within the staining patterns of the same cell types. It has the further advantages of rapidity and objectivity in comparison with traditional immunohistopathological methods. However, the validation process of this new method requires a close collaboration with the traditional histopathologic evaluation. The LSC technique is also particularly well suited for the analysis of small specimens, such as those obtained from toxicological studies. New applications for the LSC take advantage of the ability to measure multiple specimens on the same microscope slide-making it easier for instance to analyze growing cells in multi-chamber devices.
Laser scanning cytometry has been used in our unit for rat blood cell immunophenotyping , tumor proliferation, apoptosis and cell cycle analysis on minipig, rat skin and cardiac cells identi cation (15, 16) . The wide range of applications that can be applied with the LSC shows the enormous potential of this technology in research and development (1) (2) (3) (4) (5) .
CONFOCAL MICROSCOPY
Confocal laser scanning microscopy (CLSM) is a light microscopical imaging technique which produces high resolution images and optical sections through thick tissue specimens (e.g., an entire cell or a piece of tissue up to 250 m thick). This property of the CLSM is fundamental for solving 3-D biological problems where information from regions distant from the plane of focus can obscure the image (thick objects). As a valuable by-product, the computer-controlled CLSM produces digital images which are readily available for image analysis and processing, and can also be used to compute surface-or volume-rendered 3-D reconstructions of the specimen (12) .
Confocal laser scanning microscope was used in our laboratory, in collaboration with the research department, to investigate the mechanisms underlying hepatic lesions found in dogs, to detect brinogen in ux into rat lung, to explore the mechanism of eye toxicity and to quantify dopaminergic bers in brain sections.
CELL CYCLE EVALUATION BY LSC The usefulness of these new technologies for discovery pathology will be illustrated by the following example where LSC was used for cell cycle evaluation.
This work deals with the identi cation of mitotic cells, a problem that has biological and clinical signi cance, but has been dif cult to resolve with ow cytometry. Minipigs were dermally administered with an anti-proliferative compound at concentrations of 0% (placebo), 0.2%, 0.6% and 1% twice a day on a seven-day per week basis for two weeks. Three males and three females per group were used in the main study design. For the recovery study two males and two females per group were treated for two weeks twice a day on a seven-day per week basis with the compound at 0% and 1% and were allowed for recovery for two further weeks.
At necropsy, skin from the treated and untreated animals was taken for laser scanning cytometry investigations. The trypsin cell isolation procedure described previously for human samples (6) was used, with some modi cations, in order to obtain a single epidermal cell suspension. After isolation, cells were centrifuged onto slides, xed in ice-cold methanol and stored at 20 C until analysed. For cell cycle studies, the slides were incubated in a solution of Propidium Iodide (PI) containing RNAse A and Triton X-100. The slides were then coversliped and analyzed with the LSC. The uorescence emission of the stained cells was measured on the LSC interfaced to a Compaq computer equipped with the WinCyte 2.1 software. The scan area was adjusted to the entire coverslip area and > 5000 cells were counted. According to previous work (9), analysis of uorescence peak (which represents the maximal uorescence value among all the pixels over the measured cell) and uorescence area (which represents the number of pixels over threshold) of the cells stained with PI appeared to be a sensitive probe of chromatin structure, discerning cells differing in the degree of nuclear chromatin condensation. The peak and area properties are not linearly related to the amount of DNA of the cells, but give the degree of condensation of the chromatin and the size of the nucleus. Thus, based on an analysis of the uorescence parameters mentioned above, we were able to easily distinguish mitotic cells from interphase cells (Figure 1) .
Results obtained when minipigs were treated with the antimitotic compound are represented in Figures 2 and 3 . Continuous application of the compound on minipig skin induced, in male and females, a dose-related accumulation of cells in the M phase from the cell cycle when compared with the placebo (Figures 2, 3) and may re ect division failure. Moreover, the concomitant decrease of the percentage of cells in the G1 phase further con rms a cell cycle arrest of epidermal cells (11) . Presence of mitotic gures was also detected by histopathologica l evaluation of the skin. These effects were reversed after a 2-week recovery period (Figures 2, 3) .
In parallel, assessment of the regulating proteins for apoptosis resulted in an elevated Bax/Bcl-2 ratio providing conditions facilitating activation of the apoptotic machinery in epidermal cells. Histopathological diagnostic also revealed an accumulation of apoptotic bodies in the epidermis (11) .
In summary, our results showed in accordance with histopathologica l evaluation, that the mechanism of action of the compound is the elimination of growth-arrested keratinocytes by apoptosis, rather than necrosis.
CONCLUSION
Integrating these technologies within discovery pathology allowed us to understand disease processes with respect to their development and subsequent consequences. It highlights the added value, further contributes to descriptive pathologic diagnostic and allows a productive interaction with research and development. These technologies offers a range of novel applications and have been shown to represent useful tools in terms of speci city, sensitivity, reliability, rapidity and quanti cation. Expertise in cutting-edge technologies, in pathology and in cell and molecular biology
